8-K: ChromaDex Boosts CEO Robert Fried's Compensation with Salary Increase and Performance-Based Stock Units

ChromaDex Corporation amends CEO Robert Fried's employment agreement, increasing his base salary and granting performance stock units tied to stock price appreciation.

Summary

• ChromaDex Corporation has amended its executive employment agreement with CEO Robert Fried, effective February 25, 2025.
• The amendment includes an increase in his base salary to $650,000, retroactive to January 1, 2025.
• Mr. Fried's target performance bonus opportunity will be 75% of his base salary, commencing with fiscal year 2025.
• The company granted Mr. Fried 1,518,600 performance stock units (PSUs) that may be settled with shares of common stock upon achievement of incremental stock price performance targets.
• The PSUs are eligible to vest during a seven-year performance period based on the achievement and maintenance of volume weighted average price (VWAP) thresholds for a minimum of 60 trading days.
• The stock price targets range from $15 to $50, with specific numbers of PSUs vesting at each level.
• Vested shares will be subject to transfer restrictions for five years from the date of grant or until a change in control.
• If Mr. Fried's employment is terminated without cause or he resigns for good reason, unvested PSUs will remain outstanding and eligible to vest for 12 months following termination.
• The board considered Mr. Fried's leadership performance, the company's performance, and the goals of retaining Mr. Fried to continue in his role as Chief Executive Officer to execute on the Company's strategic priorities while providing compelling upside and incentive by setting performance targets which the Compensation Committee and the Board believe to be achievable but would constitute extraordinary results for the Company's stockholders.

Sentiment

Score: 7

Explanation: The document reflects a positive sentiment due to the increased compensation for the CEO and the potential for significant rewards based on company performance. The structure of the compensation package aligns management's interests with shareholders, which is generally viewed favorably.

Positives

• The performance-based stock units align the CEO's interests with those of the shareholders by incentivizing stock price appreciation.
• The vesting schedule provides a clear roadmap for achieving the performance targets.
• The transfer restrictions on vested shares encourage long-term commitment from the CEO.
• The provision for continued vesting after termination without cause or resignation for good reason provides some security for the CEO.

Negatives

• The performance targets may be difficult to achieve, potentially leading to forfeiture of the PSUs.
• The transfer restrictions on vested shares may limit the CEO's ability to access the value of the shares.
• There is no interpolation or partial issuance for achievements between stock price thresholds, nor are there any cash-out or cash-pay features of the PSUs.

Risks

• Failure to achieve the stock price targets could result in the CEO not receiving the full value of the performance-based compensation.
• Changes in market conditions or the company's performance could impact the likelihood of achieving the targets.
• The transfer restrictions on vested shares could limit the CEO's ability to respond to personal financial needs.

Future Outlook

The company aims to incentivize and retain its CEO through performance-based compensation tied to stock price appreciation, with the goal of achieving extraordinary results for stockholders.

Management Comments

• The Compensation Committee and the Board believe the performance targets to be achievable but would constitute extraordinary results for the Company's stockholders.

Industry Context

Executive compensation packages often include a mix of base salary, performance-based bonuses, and stock options or restricted stock units to align management's interests with those of shareholders. The use of performance stock units tied to specific stock price targets is a common practice to incentivize long-term value creation.

Comparison to Industry Standards

• Comparing ChromaDex's CEO compensation structure to similar companies in the nutraceutical or consumer health industries would provide a better benchmark.
• Companies like Herbalife, USANA Health Sciences, or Nu Skin Enterprises could be considered for comparison, focusing on their CEO's base salary, bonus structure, and equity compensation.
• Analyzing the percentage of performance-based compensation in relation to total compensation would also be a relevant comparison point.
• Industry surveys on executive compensation can provide data on average CEO salaries and equity grants for companies of similar size and revenue.

Stakeholder Impact

• Shareholders may view the performance-based compensation positively as it aligns the CEO's interests with stock price appreciation.
• Employees may be motivated by the potential for company success and stock price growth.
• The CEO is incentivized to drive company performance and create value for stakeholders.

Next Steps

• The CEO will need to achieve the stock price targets for the PSUs to vest.
• The Compensation Committee will certify achievement of the share price performance goals.
• The company will issue shares of common stock upon vesting of the PSUs.
• The company will monitor the CEO's performance and the company's stock price.

Key Dates